Coronavirus Update: FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new cases

by | Jan 27, 2023 | Stock Market

A Food and Drug Administration advisory panel voted unanimously Thursday for Americans to get a once-a-year booster against COVID-19, with the strain to be decided midyear for a fall campaign, the Associated Press reported.  “This is a consequential meeting to determine if we’ve reached the point in the pandemic that allows for simplifying the use of current COVID-19 vaccines,” said the FDA’s Dr. David Kaslow.

The panel agreed that people should get the same vaccine formula whether they’re receiving their initial vaccinations or a booster. Today, Americans get one formula based on the original coronavirus strain that emerged in 2020 for their first two or three doses, and their latest booster is a combination shot made by Pfizer
PFE,
-0.34%
or Moderna
MRNA,
-2.20%
that adds protection against omicron. The FDA would have to decide how to phase in t …

Article Attribution | Read More at Article Source

Share This